Prejudice is a big mountain, but mature people will constantly remove the mountain in their hearts. Now I want to revise my view that the DeSci project belongs to DEI's junk assets. After tracking Bio Protocol for a period of time, I believe that DeSci, like RWA and PayFi, will become a segmented track with real revenue, real application scenarios, and real externalities in this industry cycle (2025-2029). Why do you say that? What is the innovation path of traditional medicine? Working behind closed doors → Applying for patents → High priced authorization → Patients paying the bill. DeSci DAO follows the path of open research, data sharing, collaborative innovation, and community benefits. In the DeSci DAO model, scientists monetize their research achievements through the reputation of the DeSci community and the DeSci DAO token, rather than monopolizing patent rights. This is one of the important reasons why Bio Protocol, as the leader of DeSci, is promoting the DeSci DAO launch pad. At present, MycoDAO, the first phase of DeSci DAO focused on fungal research, has completed fundraising, raising nearly $400000. The second fundraising project is SpineDAO, which focuses on addressing the pain points of 600 million spinal patients worldwide. It has raised $600000 and is still growing. Currently, over 120 spine surgeons from 15+countries have joined SpineDAO, including Dr. Virgine Lafage from New York University, who has over 650 peer-reviewed academic papers and is recognized as an authoritative expert in the field. This expert network provides SpineDAO with a solid medical foundation and global influence. The SpineDAO program incentivizes patients and doctors to share data through SPINE, which will then be desensitized and used to train specialized medical AI agents to improve treatment efficiency and effectiveness for spinal disease patients. Of course, to achieve the above goals, it is not possible to rely solely on token economics. SpineDAO has also built a complete product matrix for it: --Filter: An AI driven screening tool that optimizes treatment pathways and promotes data sharing through token incentives; --DeScide: provides predictive models and decision support for spinal surgeons, based on expert annotated datasets, to significantly reduce surgical risks and improve success rates; --RadiomiX: Standardized interpretation of spinal related medical images to address the issue of inconsistent diagnostic criteria among different doctors and hospitals; --LAMINA: The first AI agent dedicated to spinal care, capable of providing personalized guidance and tracking for patients. Under the SpineDAO model, up to 47% of spinal medical data that has been locked in hospitals and research institutions for a long time is transformed into analyzable and applicable resources, creating value for 600 million spinal disease patients worldwide by solving the problem of data silos in the traditional healthcare industry. Through the combination of blockchain and AI, SpineDAO redefines the value capture of medical data, providing a practical template for decentralized healthcare innovation and representing the future direction of traditional healthcare's transformation towards decentralization. above.